Life Science Product News

02/12/2021

Bio-Rad’s Multi-Target Reliance SARS-CoV-2/FluA/FluB RT-PCR and Reliance SARS-CoV-2 RT-PCR Assay Kits Granted FDA Emergency Use Authorization

Bio-Rad announced that its Reliance SARS-CoV-2/FluA/FluB RT-PCR and Reliance SARS-CoV-2 RT-PCR Assay Kits were granted Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA).

02/08/2021

Bio-Rad’s Droplet Digital PCR Technology Highlighted for Cell and Gene Therapy Quality Control at Recent Analytical Development Conferences

Studies address how ddPCR technology is helping to alleviate an array of pain points in cell and gene therapy QC in the areas of product safety testing, QC scale-up, and contamination detection.

01/20/2021

Bio-Rad Launches Its Western Blot Learning Center, an Online Multi-media Library of Resources on Immunoblotting

The Western Blot Learning center provides comprehensive resources, information, and guidance to help researchers improve their experimental western blotting approaches to obtain high-quality data.

01/20/2021

Bio-Rad Holds Panel Session to Discuss COVID-19 Therapeutics Landscape at the ‘21st Century Precision Medicine in the Age of COVID-19’ Event on January 26

Bio-Rad will chair a panel session that focuses on the current therapeutic landscape of SARS-CoV-2, the virus associated with COVID-19, and how the pandemic is in many ways transforming global medical research.

11/24/2020

Bio-Rad Awards Scholarships to High School and Undergraduate Science Teachers to Attend Virtual National Science Teaching Association Teaching Conference

Bio-Rad awarded 25 scholarships to U.S. high school and undergraduate teachers from underrepresented communities to attend the National Science Teaching Association (NSTA) virtual conference, NSTA Engage: Fall20.

11/03/2020

Bio-Rad Introduces Reliance Select cDNA Synthesis Kit, a Reverse Transcription Solution that Efficiently Converts RNA to DNA

The kit provides a way for researchers to obtain highly sensitive and reproducible results.

10/07/2020

Bio-Rad Announces the Global Launch of the CFX Opus 96 and CFX Opus 384 Real-Time PCR Systems and BR.io, Web-Based Data Management and Analysis Software

The PCR systems represent the next generation of Bio-Rad’s CFX Real-time PCR products that are used in research and genomic testing as well pathogen detection and infectious disease testing.

07/27/2020

Scientists Demonstrated the Sensitivity and Reliability of Bio-Rad’s Droplet Digital PCR in Clinical Oncology at AACR 2020

More than 45 abstracts were presented showing the value of Droplet Digital PCR (ddPCR) technology as a tool for quantifying cancer biomarkers

06/17/2020

Bio-Rad Products Provide Support in the Fight against COVID-19

Bio-Rad continues to support the worldwide effort to fight SARS-CoV-2, the virus associated with COVID-19 disease, offering instruments, tests, and a SARS-CoV-2 standard to help labs validate COVID-19 assay results.

05/17/2020

FDA Lists Bio-Rad’s CFX96 Dx Real-Time PCR System for IVD Testing

Bio-Rad Laboratories Inc. announced that its CFX96 Dx Real-Time PCR System has been listed with the U.S. Food and Drug Administration (FDA) for IVD testing and may be used to help in the diagnosis of COVID-19.